Journal of Hazardous Materials
Associations between air pollution and cardiorespiratory function and metabolic indicators: New insights into mixture exposures
Study in peoplePopulations
Papers by Xiaoying Li
8 results
- ADA Scientific Sessions 2026 Abstract
Efficacy and Safety of Oral Ribupatide (HRS9531) in Adults with Obesity: A Phase 2 Trial
Trial in peopleInterventions - ADA Scientific Sessions 2026 Abstract
Efficacy and Safety of a Novel Oral Small Molecule GLP-1 Receptor Agonist HDM1002 in Chinese Overweight and Obese Adults: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial
Trial in peopleInterventions
- ADA Scientific Sessions 2026 Abstract
Efficacy and Safety of Dual GLP-1/GIP Receptor Agonist HDM1005 in Obese Participants without Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial
Trial in peopleInterventions - ADA Scientific Sessions 2025 Abstract
Efficacy and Safety of a Novel Dual GLP-1/GIP Receptor Agonist (HRS9531), in Obese Adults without Diabetes—Up to 52-Week Treatment
Trial in peopleInterventions - ADA Scientific Sessions 2025 Abstract
HDM1002 in Chinese Adults with Overweight or Obesity—A Randomized, Placebo-Controlled, Four-Week, Phase 1b Study
Trial in peopleInterventions - ADA Scientific Sessions 2025 Abstract
A Phase 3 Evaluation of CAMP-Biased GLP-1 Analog Ecnoglutide vs. Dulaglutide in Adults with Type 2 Diabetes
Trial in peopleInterventions